Perhaps it would've led to a de facto ban on expensive-to-produce insulin variants. Giving Medicare prescription negotiating authority and requiring that that

Perhaps it would've led to a de facto ban on expensive-to-produce insulin variants. Giving Medicare prescription negotiating authority and requiring that that be the maximum retail price would be the answer.